ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 651607 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 651607; 2) Community: the network communities that were significantly associated with the response to NSC 651607; 3) Molecule: the relationships between components within communities and NSC 651607; 4) MDR: the compounds that were significantly associated with the NSC 651607.

NSC Compound Enrichment Correlation
NSC 702047 2-Propenone, 1,1'-(2,5-pyridinediyl)bis[3-(2-furanyl)- 0.0462077035966091 0.016454439
NSC 707465 2-Butenoic acid, 4-[[4,5-dichloro-2-[[[[2-(1-pyrrolidinyl)cyclohexyl] (methyl)amino]carbonyl]methyl]phenyl]amino]-4-oxo-, methyl ester, (1S,2S)- 0.0462077035966091 -0.093968628
NSC 109825 Null 0.0467178916101838 0.20473712
NSC 175630 Toyocamycin, 6-amino- 0.0467178916101838 0.045989868
NSC 3091 Ammonium, [.alpha.-[p-(dimethylamino)phenyl]-.alpha.-[4-(dimethyliminio)-2,5-cyclohexadien-1-ylidene]-p-tolyl]ethyldimethyl-, bromide, chloride (8CI) 0.0467178916101838 0.20960868
NSC 362454 4-Pyridazinecarbonitrile, 5,6-bis(4-fluorophenyl)-2,3-dihydro-2-(2-hydroxyethyl)-3-oxo- 0.0467178916101838 0.087407933
NSC 363979 Cephalostatin 1 0.0467178916101838 0.20346881
NSC 621326 Null 0.0467178916101838 0.1089987
NSC 628572 Null 0.0467178916101838 -0.055156879
NSC 649150 Null 0.0467178916101838 -0.063860733
Total:52  Current:49    [First] [Prev] [Next] [Last]